Issue navigation
Volume 58, Issue 1, January 2019
EDITORIALS
Hello from the new Editor-in-Chief
Rheumatology, Volume 58, Issue 1, January 2019, Pages 1–2, https://doi.org/10.1093/rheumatology/key378
Monitoring for retinal toxicity in patients taking hydroxychloroquine and chloroquine
Rheumatology, Volume 58, Issue 1, January 2019, Pages 3–4, https://doi.org/10.1093/rheumatology/key024
REVIEWS
Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment
Rheumatology, Volume 58, Issue 1, January 2019, Pages 5–17, https://doi.org/10.1093/rheumatology/key006
The patient experience of Raynaud’s phenomenon in systemic sclerosis
Rheumatology, Volume 58, Issue 1, January 2019, Pages 18–26, https://doi.org/10.1093/rheumatology/key026
Gout: state of the art after a decade of developments
Rheumatology, Volume 58, Issue 1, January 2019, Pages 27–44, https://doi.org/10.1093/rheumatology/key002
CLINICAL SCIENCE
Validation of the Musculoskeletal Health Questionnaire in inflammatory arthritis: a psychometric evaluation
Rheumatology, Volume 58, Issue 1, January 2019, Pages 45–51, https://doi.org/10.1093/rheumatology/key240
Efficacy and safety of low dose Mycophenolate mofetil treatment for immunoglobulin G4-related disease: a randomized clinical trial
Rheumatology, Volume 58, Issue 1, January 2019, Pages 52–60, https://doi.org/10.1093/rheumatology/key227
Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of gout
Rheumatology, Volume 58, Issue 1, January 2019, Pages 61–69, https://doi.org/10.1093/rheumatology/key245
Modified- versus immediate-release tofacitinib in Japanese rheumatoid arthritis patients: a randomized, phase III, non-inferiority study
Rheumatology, Volume 58, Issue 1, January 2019, Pages 70–79, https://doi.org/10.1093/rheumatology/key250
Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register
Rheumatology, Volume 58, Issue 1, January 2019, Pages 80–85, https://doi.org/10.1093/rheumatology/key241
Is joint pain in patients with arthralgia suspicious for progression to rheumatoid arthritis explained by subclinical inflammation? A cross-sectional MRI study
Rheumatology, Volume 58, Issue 1, January 2019, Pages 86–93, https://doi.org/10.1093/rheumatology/key220
Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra
Rheumatology, Volume 58, Issue 1, January 2019, Pages 94–102, https://doi.org/10.1093/rheumatology/key262
Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome
Rheumatology, Volume 58, Issue 1, January 2019, Pages 103–109, https://doi.org/10.1093/rheumatology/key260
Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in routine care – 2-year outcomes and predictors
Rheumatology, Volume 58, Issue 1, January 2019, Pages 110–119, https://doi.org/10.1093/rheumatology/key244
Significance of nailfold videocapillaroscopy in patients with idiopathic inflammatory myopathies
Rheumatology, Volume 58, Issue 1, January 2019, Pages 120–130, https://doi.org/10.1093/rheumatology/key257
The effects of methotrexate and hydroxychloroquine combination therapy vs methotrexate monotherapy in early rheumatoid arthritis patients
Rheumatology, Volume 58, Issue 1, January 2019, Pages 131–134, https://doi.org/10.1093/rheumatology/key275
Thymectomy in patients with myasthenia gravis increases the risk of autoimmune rheumatic diseases: a nationwide cohort study
Rheumatology, Volume 58, Issue 1, January 2019, Pages 135–143, https://doi.org/10.1093/rheumatology/key236
Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study
Rheumatology, Volume 58, Issue 1, January 2019, Pages 144–148, https://doi.org/10.1093/rheumatology/key286
Autoantibody status is not associated with early treatment response to first-line methotrexate in patients with early rheumatoid arthritis
Rheumatology, Volume 58, Issue 1, January 2019, Pages 149–153, https://doi.org/10.1093/rheumatology/key263
BASIC AND TRANSLATIONAL SCIENCE
PIM-1 kinase is a novel regulator of proinflammatory cytokine-mediated responses in rheumatoid arthritis fibroblast-like synoviocytes
Rheumatology, Volume 58, Issue 1, January 2019, Pages 154–164, https://doi.org/10.1093/rheumatology/key261
Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers
Rheumatology, Volume 58, Issue 1, January 2019, Pages 165–178, https://doi.org/10.1093/rheumatology/key223
LETTERS TO THE EDITOR
OTHER
Changes in antibody titres in patients with anti-transcription intermediary factor 1-gamma antibody-positive idiopathic inflammatory myositis
Rheumatology, Volume 58, Issue 1, January 2019, Pages 179–181, https://doi.org/10.1093/rheumatology/key310
CASE REPORTS
Novel CECR1 gene mutations causing deficiency of adenosine deaminase 2, mimicking antiphospholipid syndrome
Rheumatology, Volume 58, Issue 1, January 2019, Pages 181–182, https://doi.org/10.1093/rheumatology/key258
Expanding clinical spectrum of autosomal dominant pyrin-associated autoinflammatory disorder caused by the heterozygous MEFV p.Thr577Asn variant
Rheumatology, Volume 58, Issue 1, January 2019, Pages 182–184, https://doi.org/10.1093/rheumatology/key283
MATTERS ARISING
Comment on: Should Rheumatology be a core discipline of a chronic pain multi-disciplinary team?
Rheumatology, Volume 58, Issue 1, January 2019, Pages 184–185, https://doi.org/10.1093/rheumatology/key320
Comment on: Should Rheumatology be a core discipline of a chronic pain multi-disciplinary team?: reply
Rheumatology, Volume 58, Issue 1, January 2019, Pages 185–186, https://doi.org/10.1093/rheumatology/key318
CLINICAL VIGNETTES
Necrotic erythema nodosum leprosum masquerading as cutaneous vasculitis
Rheumatology, Volume 58, Issue 1, January 2019, Page 85, https://doi.org/10.1093/rheumatology/key216
Scrotal calcinosis in an adult patient with amyopathic dermatomyositis
Rheumatology, Volume 58, Issue 1, January 2019, Page 164, https://doi.org/10.1093/rheumatology/key183
GLOBAL NEWS ITEM
MYOSITIS, 1st edition, edited by H. Chinoy and R.G. Cooper
Rheumatology, Volume 58, Issue 1, January 2019, Page e1, https://doi.org/10.1093/rheumatology/key321
CORRIGENDUM
Tofacitinib for psoriatic arthritis (PsA) is now approved by the European Commission
Rheumatology, Volume 58, Issue 1, January 2019, Page e2, https://doi.org/10.1093/rheumatology/key333
